Citius Oncology Reports Q3 Fiscal 2026 Results

What Happened Citius Oncology, Inc. announced its results of operations for the third quarter of fiscal 2026 via a press release dated August 14, 2026. The company filed a Form 8‑K (Item 2.02) furnishing that press release, which is included as Exhibit 99.1 to the filing.

Key Details

• Filed Form 8-K on August 14, 2026 reporting results of operations and financial condition (Item 2.02).
• Press release announcing Q3 fiscal 2026 results is furnished as Exhibit 99.1 to the 8‑K.
• The filing also includes the Inline XBRL cover page (Exhibit 104).
• The 8‑K itself furnishes the press release rather than embedding the full financial statements in the Form 8‑K.

Why It Matters Quarterly results are a primary source of updated information on a company’s earnings, revenue trends and cash position; they can affect investor expectations and share price. Investors should read the attached press release (Exhibit 99.1) for the specific revenue, profit/loss, cash balance and any management commentary or guidance, and consult Citius Oncology’s subsequent SEC filings (e.g., Form 10‑Q) for reconciled financial statements and additional detail.